Document Detail


Novel fluorescent technology platform for high throughput cytotoxicity and proliferation assays.
MedLine Citation:
PMID:  10894757     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We have developed a novel fluorescent Oxygen BioSensor technology platform adaptable to many applications in the area of drug discovery and development, particularly cell-based assays. This biosensor technology requires no additional reagents or incubations, and affords continuous real-time readout of dissolved oxygen concentrations. Since the level of oxygen dissolved in an assay's medium correlates to the number and viability of the cells in the medium, this technology is ideally suited for monitoring cell viability, proliferation, or death. The technology is particularly well suited to investigating cells' kinetic responses to proliferative or toxic stimuli, such as drugs. When incorporated into a 96- or 384-well microplate format, it is compatible with standard laboratory automation systems. Here we present data illustrating the application of the Oxygen BioSensor technology for rapid, homogeneous detection and evaluation of metabolic activity of a variety of eukaryotic and prokaryotic cells, including mammalian cells, insect cells, yeast, and bacteria. In the absence of toxic substances, we find a good correlation between cell number and signal over a wide range of cell concentrations and growth times. To evaluate the usefulness of the Oxygen BioSensor for cytotoxicity assays, we have performed a series of experiments using a range of toxic agents and cell types, including both bacteria and mammalian cell lines. In a side-by-side comparison to standard MTT assays using HL60 cells, comparable IC(50) values were found with the Oxygen BioSensor for five different toxins or drugs. This assay method does not have the need for additional reagents, handling steps, or incubation periods required by the MTT assays.
Authors:
M Wodnicka; R D Guarino; J J Hemperly; M R Timmins; D Stitt; J B Pitner
Related Documents :
18068747 - Study of cell killing effect on s180 by ultrasound activating protoporphyrin ix.
19194067 - Intervention of oxygen-control ability to radiation sensitivity, cell aging and cell tr...
11729237 - Manganese superoxide dismutase attenuates cisplatin-induced renal injury: importance of...
2748937 - Misonidazole chemosensitization of emt6 spheroids to melphalan.
3805027 - Immunological evidence for gap junction polypeptide in plant cells.
15993867 - N-acyl derivatives of glucosamine as acceptor substrates for galactosyltransferase from...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of biomolecular screening     Volume:  5     ISSN:  1087-0571     ISO Abbreviation:  J Biomol Screen     Publication Date:  2000 Jun 
Date Detail:
Created Date:  2000-08-09     Completed Date:  2000-08-09     Revised Date:  2011-05-23    
Medline Journal Info:
Nlm Unique ID:  9612112     Medline TA:  J Biomol Screen     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  141-52     Citation Subset:  IM    
Affiliation:
BD Technologies, Research Triangle Park, NC 27709, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Anti-Bacterial Agents / pharmacology
Biosensing Techniques*
Cell Division / drug effects
Cell Line
Fluorescent Dyes
Humans
Microbial Sensitivity Tests
Oxygen
Spectrometry, Fluorescence / methods*
Chemical
Reg. No./Substance:
0/Anti-Bacterial Agents; 0/Fluorescent Dyes; 7782-44-7/Oxygen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Large-scale screening assay to measure epidermal growth factor internalization.
Next Document:  Development of a high throughput scintillation proximity assay for hepatitis C virus NS3 protease th...